Avricore Health (AVCRF) Share-based Compensation (IS) (2015 - 2025)
Avricore Health (AVCRF) reported Share-based Compensation (IS) of $37426.1 for Q3 2025, down 84.9% year-over-year from $247837.3 in Q3 2024, and down 59.6% quarter-over-quarter from $92634.0 in Q2 2025.
Avricore Health (AVCRF) Share-based Compensation (IS) (2015 - 2025) Analysis & Trends
Avricore Health (AVCRF) has 11 years of Share-based Compensation (IS) data on file, last reported at $37426.1 in Q3 2025.
- Share-based Compensation (IS) for Q3 2025 came in at $37426.1, down 84.9% year-over-year; the trailing twelve-month figure through Sep 2025 was $421009.3 (up 12.49% YoY), and the FY2025 annual result was $200886.5, down 49.18% from the prior year.
- Share-based Compensation (IS) eased to $37426.1 in Q3 2025 per AVCRF's latest filing, from $92634.0 in the prior quarter.
- Over five years, Share-based Compensation (IS) peaked at $305717.0 in Q1 2021 and troughed at $1168.4 in Q2 2024.
- A 5-year average of $89176.3 and a median of $52051.3 in 2021 frame the typical range for Share-based Compensation (IS).
- The sharpest annual moves came in 2024 and 2025: Share-based Compensation (IS) tumbled 99.07% in 2024, then jumped 7828.53% in 2025.
- A 5-year view of Share-based Compensation (IS) shows it stood at $7274.1 in 2021, then jumped by 2361.04% to $179018.8 in 2022, then plunged by 41.42% to $104866.0 in 2023, then soared by 136.34% to $247837.3 in 2024, then sank by 84.9% to $37426.1 in 2025.
- Business Quant data shows AVCRF's Share-based Compensation (IS) at $37426.1 in Q3 2025, $92634.0 in Q2 2025, and $43112.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | - |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | - |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | - |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | - |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | - |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | - |
| 10 | Avricore Health | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 37,426.06 |
| Sep 30, 2025 | 37,426.06 |
| Jun 30, 2025 | 92,633.96 |
| Jun 30, 2025 | 92,633.96 |
| Mar 31, 2025 | 43,111.95 |
| Mar 31, 2025 | 43,111.95 |
| Sep 30, 2024 | 247,837.29 |
| Sep 30, 2024 | 247,837.29 |
| Jun 30, 2024 | 1,168.36 |
| Jun 30, 2024 | 1,168.36 |
| Mar 31, 2024 | 20,381.40 |
| Mar 31, 2024 | 20,381.40 |
| Dec 31, 2023 | 104,865.96 |
| Dec 31, 2023 | 104,865.96 |
| Sep 30, 2023 | 227,007.53 |
| Sep 30, 2023 | 227,007.53 |
| Jun 30, 2023 | 125,453.64 |
| Jun 30, 2023 | 125,453.64 |
| Mar 31, 2023 | 65,094.02 |
| Mar 31, 2023 | 65,094.02 |